•
Mar 31, 2024

Solid Biosciences Q1 2024 Earnings Report

EPS
-$0.64
Previous year: -$1.54
-58.4%
Gross Profit
-$327K
Cash and Equivalents
$206M
Previous year: $165M
+25.2%
Free Cash Flow
-$25.3M
Previous year: -$28.5M
-11.1%
Total Assets
$249M
Previous year: $230M
+8.3%

Solid Biosciences

Solid Biosciences